Systematic Financial Management LP Purchases New Position in AdaptHealth Corp. (NASDAQ:AHCO)

Systematic Financial Management LP acquired a new position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 98,958 shares of the company's stock, valued at approximately $1,111,000. Systematic Financial Management LP owned about 0.07% of AdaptHealth as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Canada Pension Plan Investment Board bought a new stake in shares of AdaptHealth in the second quarter worth $58,000. Quarry LP grew its stake in shares of AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company's stock worth $67,000 after purchasing an additional 5,838 shares during the last quarter. Blue Trust Inc. bought a new stake in shares of AdaptHealth in the second quarter worth $85,000. Innealta Capital LLC bought a new stake in shares of AdaptHealth in the second quarter worth $101,000. Finally, Quest Partners LLC grew its stake in shares of AdaptHealth by 11,522.7% in the second quarter. Quest Partners LLC now owns 10,228 shares of the company's stock worth $102,000 after purchasing an additional 10,140 shares during the last quarter. Institutional investors own 82.67% of the company's stock.

Insider Activity

In related news, COO Shaw Rietkerk sold 25,000 shares of the firm's stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $11.24, for a total value of $281,000.00. Following the transaction, the chief operating officer now owns 212,611 shares of the company's stock, valued at approximately $2,389,747.64. This trade represents a 10.52 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.43% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Robert W. Baird cut their price target on shares of AdaptHealth from $16.00 to $14.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 6th. Royal Bank of Canada cut their price target on shares of AdaptHealth from $13.00 to $11.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 19th. Truist Financial cut their price target on shares of AdaptHealth from $13.00 to $12.00 and set a "buy" rating on the stock in a research report on Friday, November 15th. Canaccord Genuity Group cut their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Wednesday, November 6th. Finally, UBS Group cut their price target on shares of AdaptHealth from $13.00 to $12.00 and set a "buy" rating on the stock in a research report on Wednesday, November 6th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $11.67.

AdaptHealth Stock Up 0.1 %

Shares of NASDAQ AHCO traded up $0.01 during trading on Friday, hitting $9.73. 625,649 shares of the company traded hands, compared to its average volume of 1,053,872. The business's fifty day moving average is $10.29 and its 200 day moving average is $10.45. AdaptHealth Corp. has a fifty-two week low of $6.43 and a fifty-two week high of $11.90. The firm has a market capitalization of $1.31 billion, a price-to-earnings ratio of -5.90, a P/E/G ratio of 1.34 and a beta of 1.10. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.02). AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The company had revenue of $805.90 million for the quarter, compared to analyst estimates of $809.32 million. During the same quarter in the prior year, the company posted $0.19 EPS. AdaptHealth's revenue for the quarter was up .2% on a year-over-year basis. Equities research analysts predict that AdaptHealth Corp. will post 0.88 earnings per share for the current fiscal year.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.